AllPennyStocks.com Why Is CAPR Stock Rising Today?
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Why Is CAPR Stock Rising Today?

The U.S. Food and Drug Administration extended its review of the biotech firm’s experimental Duchenne muscular dystrophy treatment, Deramiocel, by three months.

Other Penny Stock Movers

Financial Tech Junior Surges 18% Following Reaffirmation of US$15.8M Digital Treasury
Quebec Gold Explorer Jumps 16% on C$57M Strategic Backing
$4.5 Million Could Unlock a Major Cannabis Market
Most Popular
{{ index + 1 }}


Back to Top